PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2019

Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis.

Rat / Other

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31176170 ↗2019Reported benefit

Human umbilical cord mesenchymal stem cells pretreated with Angiotensin-II attenuate pancreas injury of rats with severe acute pancreatitis.

RatOtherIntravenous injection via the tail vein12 hours after induction of severe acute pancreatitis

Model: Severe acute pancreatitis in rats; induction method not stated in the abstract

Angiotensin II-pretreated human umbilical cord mesenchymal stem cells significantly inhibited pancreatic injury, reducing pancreatitis severity scores and serum amylase and lipase compared with untreated cells. Conditioned medium from the pretreated cells reduced HUVEC apoptosis and increased tube…

Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.